TY - JOUR T1 - Evaluating Progress in Automatic Chest X-Ray Radiology Report Generation JF - medRxiv DO - 10.1101/2022.08.30.22279318 SP - 2022.08.30.22279318 AU - Feiyang Yu AU - Mark Endo AU - Rayan Krishnan AU - Ian Pan AU - Andy Tsai AU - Eduardo Pontes Reis AU - Eduardo Kaiser Ururahy Nunes Fonseca AU - Henrique Min Ho Lee AU - Zahra Shakeri Hossein Abad AU - Andrew Y. Ng AU - Curtis P. Langlotz AU - Vasantha Kumar Venugopal AU - Pranav Rajpurkar Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/08/31/2022.08.30.22279318.abstract N2 - The application of AI to medical image interpretation tasks has largely been limited to the identification of a handful of individual pathologies. In contrast, the generation of complete narrative radiology reports more closely matches how radiologists communicate diagnostic information in clinical workflows. Recent progress in artificial intelligence (AI) on vision-language tasks has enabled the possibility of generating high-quality radiology reports from medical images. Automated metrics to evaluate the quality of generated reports attempt to capture overlap in the language or clinical entities between a machine-generated report and a radiologist-generated report. In this study, we quantitatively examine the correlation between automated metrics and the scoring of reports by radiologists. We analyze failure modes of the metrics, namely the types of information the metrics do not capture, to understand when to choose particular metrics and how to interpret metric scores. We propose a composite metric, called RadCliQ, that we find is able to rank the quality of reports similarly to radiologists and better than existing metrics. Lastly, we measure the performance of state-of-the-art report generation approaches using the investigated metrics. We expect that our work can guide both the evaluation and the development of report generation systems that can generate reports from medical images approaching the level of radiologists.Competing Interest StatementThe Authors declare no Competing Non-Financial Interests but the following Competing Financial Interests: I.P. is a consultant for MD.ai and Diagnosticos da America (Dasa). C.P.L. serves on the board of directors and is a shareholder of Bunkerhill Health. He is an advisor and option holder for GalileoCDS, Sirona Medical, Adra, and Kheiron. He is an advisor to Sixth Street and an option holder in whiterabbit.ai. His research program has received grant or gift support from Carestream, Clairity, GE Healthcare, Google Cloud, IBM, IDEXX, Hospital Israelita Albert Einstein, Kheiron, Lambda, Lunit, Microsoft, Nightingale Open Science, Nines, Philips, Subtle Medical, VinBrain, Whiterabbit.ai, the Paustenbach Fund, the Lowenstein Foundation, and the Gordon and Betty Moore Foundation.Funding StatementSupport for this work was provided in part by the Medical Imaging Data Resource Center (MIDRC) under contracts 75N92020C00008 and 75N92020C00021 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:PhysioNet approved the access of the MIMIC-CXR dataset. Please see the access section here for more details: https://physionet.org/content/mimic-cxr-jpg/2.0.0/.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in the study is available with credentialed access at: https://physionet.org/content/mimic-cxr-jpg/2.0.0/. Credentialed access can be obtained via an application to PhysioNet. https://physionet.org/content/mimic-cxr-jpg/2.0.0/ ER -